[Musculoskeletal tumors. II. Therapeutic strategy for vascular sarcoma--with special reference to the recent progress in chemotherapy].

PubWeight™: 0.75‹?›

🔗 View Article (PMID 20361437)

Published in Gan To Kagaku Ryoho on March 01, 2010

Authors

Naoya Yamazaki

Articles by these authors

Statistical profiles of malignant melanoma and other skin cancers in Japan: 2007 update. Int J Clin Oncol (2008) 1.63

Self-involution of giant keratoacanthoma on the tip of the nose. Plast Reconstr Surg (2003) 1.37

Metastatic angiosarcoma of the lung: spectrum of CT findings. AJR Am J Roentgenol (2003) 1.26

Mutant IDH1 confers an in vivo growth in a melanoma cell line with BRAF mutation. Am J Pathol (2011) 1.26

Dendritic cell-based vaccination in metastatic melanoma patients: phase II clinical trial. Oncol Rep (2012) 1.05

Identification of melanoma antigens using a Serological Proteome Approach (SERPA). Cancer Genomics Proteomics (2010) 0.99

Postmarketing surveillance study of erlotinib in Japanese patients with non-small-cell lung cancer (NSCLC): an interim analysis of 3488 patients (POLARSTAR). J Thorac Oncol (2012) 0.99

Efficacy of taxane regimens in patients with metastatic angiosarcoma. Eur J Dermatol (2011) 0.94

Applicability of radiocolloids, blue dyes and fluorescent indocyanine green to sentinel node biopsy in melanoma. J Dermatol (2011) 0.92

Erlotinib-related skin toxicities: treatment strategies in patients with metastatic non-small cell lung cancer. J Am Acad Dermatol (2013) 0.90

Cytokeratin 7 staining was useful in a case of pigmented mammary Paget's disease resembling malignant melanoma. Int J Dermatol (2006) 0.89

Clinical response in Japanese metastatic melanoma patients treated with peptide cocktail-pulsed dendritic cells. J Transl Med (2005) 0.89

Clinicopathologic significance of dysadherin expression in cutaneous malignant melanoma: immunohistochemical analysis of 115 patients. Cancer (2005) 0.88

Sentinel lymph node biopsy guided by indocyanine green fluorescence for cutaneous melanoma. Eur J Dermatol (2011) 0.87

Panitumumab in Japanese patients with unresectable colorectal cancer: a post-marketing surveillance study of 3085 patients. Jpn J Clin Oncol (2014) 0.87

Metastatic melanoma on the abdominal wall. Jpn J Clin Oncol (2009) 0.86

Syringoid eccrine carcinoma with apparently aggressive transformation: case report and review of the literature. Int J Dermatol (2006) 0.85

Cytotoxic T cell induction against human malignant melanoma cells using HLA-A24-restricted melanoma peptide cocktail. Anticancer Res (2004) 0.85

Limitation of indocyanine green fluorescence in identifying sentinel lymph node prior to skin incision in cutaneous melanoma. Int J Clin Oncol (2013) 0.84

Phase I and pharmacokinetic/pharmacodynamic study of RO5126766, a first-in-class dual Raf/MEK inhibitor, in Japanese patients with advanced solid tumors. Cancer Chemother Pharmacol (2013) 0.84

Prediction of additional lymph node positivity and clinical outcome of micrometastases in sentinel lymph nodes in cutaneous melanoma: a multi-institutional study of 450 patients in Japan. J Dermatol (2011) 0.83

Contrasting prognostic implications of platelet-derived growth factor receptor-β and vascular endothelial growth factor receptor-2 in patients with angiosarcoma. Ann Surg Oncol (2011) 0.82

Final safety and efficacy of erlotinib in the phase 4 POLARSTAR surveillance study of 10 708 Japanese patients with non-small-cell lung cancer. Cancer Sci (2014) 0.81

Identification of cytomegalovirus (CMV)pp65 antigen-specific human monoclonal antibodies using single B cell-based antibody gene cloning from melanoma patients. Immunol Lett (2010) 0.79

Clinicopathological significance of sentinel node biopsy in Japanese patients with cutaneous malignant melanoma. J Dermatol (2010) 0.78

Characterization of a MAGE-1-derived HLA-A24 epitope-specific CTL line from a Japanese metastatic melanoma patient. Anticancer Res (2009) 0.77

Novel approach to the characterization of melanoma associated-peptide-specific CTL lines from Japanese metastatic melanoma patients. Int J Oncol (2008) 0.77

MR imaging of hepatic metastasis in patients with malignant melanoma: evaluation of suspected lesions screened at contrast-enhanced CT. Eur J Radiol (2011) 0.77

Case of advanced melanoma who died from meningitis carcinomatosa after carboplatin and paclitaxel with good response. J Dermatol (2014) 0.76

A double-blind, placebo-controlled study of the safety and efficacy of vitamin K1 ointment for the treatment of patients with cetuximab-induced acneiform eruption. Jpn J Clin Oncol (2012) 0.75

A case of sentinel node metastasis of superficial spreading melanoma with two lymphatic channels. Jpn J Clin Oncol (2008) 0.75

[Keypoints in placing an intratracheal stent]. Kyobu Geka (2010) 0.75

Phase I and pharmacokinetics/pharmacodynamics study of the MEK inhibitor RO4987655 in Japanese patients with advanced solid tumors. Invest New Drugs (2015) 0.75

Characterization of cytomegalovirus pp65-HLA-A24 peptide-specific CTL lines from metastatic melanoma patients. Oncol Rep (2009) 0.75

A case of scalp angiosarcoma with lung metastases presenting as multiple thin-walled cysts. Jpn J Clin Oncol (2013) 0.75

Sentinel lymph node mapping of melanoma using technetium-99m phytate by a hybrid single-photon emission computed tomography/computed tomography. J Dermatol (2014) 0.75